Sponsor:
Pasithea Therapeutics Corp.
Code:
NCT06299839
Conditions
RAS Mutation
NF1 Mutation
RAF Mutation
Advanced Solid Tumors
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PAS-004 Capsules
PAS-004 Tablets
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-30. This information was provided to ClinicalTrials.gov by Pasithea Therapeutics Corp. on 2025-08-21.